First Time Loading...

Verona Pharma PLC
NASDAQ:VRNA

Watchlist Manager
Verona Pharma PLC Logo
Verona Pharma PLC
NASDAQ:VRNA
Watchlist
Price: 14.75 USD -0.87% Market Closed
Updated: May 10, 2024

Verona Pharma PLC
Operating Income

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Verona Pharma PLC
Operating Income Peer Comparison

Comparables:
GSK
AZN
INDV
HIK
DPH

Competitive Operating Income Analysis
Latest Figures & CAGR of Competitors

Company Operating Income CAGR 3Y CAGR 5Y CAGR 10Y
Verona Pharma PLC
NASDAQ:VRNA
Operating Income
-$67.6m
CAGR 3-Years
3%
CAGR 5-Years
-15%
CAGR 10-Years
N/A
GlaxoSmithKline PLC
LSE:GSK
Operating Income
£7.3B
CAGR 3-Years
0%
CAGR 5-Years
-2%
CAGR 10-Years
1%
AstraZeneca PLC
LSE:AZN
Operating Income
$8.6B
CAGR 3-Years
27%
CAGR 5-Years
14%
CAGR 10-Years
11%
Indivior PLC
LSE:INDV
Operating Income
$257m
CAGR 3-Years
20%
CAGR 5-Years
-5%
CAGR 10-Years
N/A
Hikma Pharmaceuticals PLC
LSE:HIK
Operating Income
$622m
CAGR 3-Years
6%
CAGR 5-Years
7%
CAGR 10-Years
6%
Dechra Pharmaceuticals PLC
LSE:DPH
Operating Income
£24.9m
CAGR 3-Years
-25%
CAGR 5-Years
-11%
CAGR 10-Years
3%

See Also

What is Verona Pharma PLC's Operating Income?
Operating Income
-67.6m USD

Based on the financial report for Dec 31, 2023, Verona Pharma PLC's Operating Income amounts to -67.6m USD.

What is Verona Pharma PLC's Operating Income growth rate?
Operating Income CAGR 5Y
-15%

Over the last year, the Operating Income growth was 11%. The average annual Operating Income growth rates for Verona Pharma PLC have been 3% over the past three years , -15% over the past five years .